I found a press release 10/2024 ATYR had a write up in Beast of chest journal.  ATYR is in Phase 2 trials for Pulmonary Sarcoidosis with positive results.  Past spikes $4.-$7.30 twice and $5.00 - $12.80.  ATYR was in a consolidation $1.67 to $2.00 broke with a ramp up then spike past prev high $2.50 10/15 broke previous high to $2.83.  Drug sector is hot, press release, break out, analyst Wells Fargo predict 1 yr target $17.00.  Thesis is wait for break above long term res level of $3.00 have a closed green above to validate new support level, buy on the break hook and go bounce off $3.00 sp $2.90 tp 10%-20%.